Samantha Truex

Samantha Truex is currently Chief Executive Officer at Oblenio Bio, Inc. since 2025, Chairman at Artios Pharma Ltd. since 2022, and Independent Director at Avalo Therapeutics, Inc. since 2024.
Former roles include Chief Executive Officer at Quench Bio, Inc. and Upstream Bio, Inc., Director at Sanofi from 1998 to 2006, Director at HotSpot Therapeutics, Inc., Vice President-Corporate Development at Biogen, Inc. from 2010 to 2014, Adviser at Atlas Venture Advisors, Inc., Chief Business Officer at Padlock Therapeutics, Inc., and Chief Operating Officer at Synlogic Therapeutics from 2016 to 2017.
Education includes an undergraduate degree from Dartmouth College in 1992, an undergraduate degree from Thayer School of Engineering at Dartmouth in 1993, and an MBA from Tuck School of Business at Dartmouth in 1995.